White House touts abortion pill as answer but FDA rules limit use

The White House quickly pointed to the abortion pill as an answer to the post-Roe world in which some 33 million women could lose access to procedures in their home states.

By

National News

July 1, 2022 - 3:24 PM

President Joe Biden listens to Governor of New York Kathy Hochul speak during a call with governors on protecting access to reproductive Health Care at the White House on July 1, 2022, in Washington, DC. (Tasos Katopodis/Getty Images/TNS)

The Biden administration says it’s taking steps to increase access to medication abortion in response to the Supreme Court decision to reverse Roe v. Wade, but some of the administration’s own policies stand in the way of people trying to get the drug.

Mifepristone, the drug known as the abortion pill, has been approved in the U.S. for more than 20 years and has been shown to be safer than commonly used drugs like Tylenol. But federal regulations strictly limit the circumstances under which patients can get it. While the administration last year loosened some rules on prescribers, it added new hurdles for pharmacies to dispense abortion pills. Several states have regulations on top of that, limiting who can prescribe it or requiring people to attend in-person doctor’s appointments to get the pill.

The White House quickly pointed to the abortion pill as an answer to the post-Roe world in which some 33 million women could lose access to procedures in their home states. President Joe Biden ordered his health officials “to identify all ways to ensure that mifepristone is as widely accessible as possible,” according to a White House statement. 

Related
July 21, 2022
June 28, 2022
June 24, 2022
May 5, 2022